George B Rodrigues
Overview
Explore the profile of George B Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan V, Correa R, Nguyen T, Louie A, Malthaner R, Fortin D, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(1):39-44.
PMID: 39362312
Purpose: For early-stage non-small cell lung cancer, surgery is the preferred approach in operable patients, whereas SABR is preferred for patients who are medically inoperable. The combination of neoadjuvant SABR...
2.
Tan V, Padayachee J, Rodrigues G, Navarro I, Shah P, Palma D, et al.
Radiother Oncol
. 2024 Aug;
200:110505.
PMID: 39197501
Introduction: The aim of this systematic review and meta-analysis was to review evidence and pool outcomes to assess the effectiveness of stereotactic ablative radiotherapy (SABR) in patients treated for oligoprogressive...
3.
Sartor O, Karrison T, Sandler H, Gomella L, Amin M, Purdy J, et al.
Eur Urol
. 2024 Jun;
86(3):289-290.
PMID: 38897867
Background: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. Objective: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of...
4.
Giuliani M, Filion E, Faria S, Kundapur V, Vu T, Lok B, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(3):669-677.
PMID: 38614279
Purpose: The use of stereotactic body radiation therapy for tumors in close proximity to the central mediastinal structures has been associated with a high risk of toxicity. This study (NCT03306680)...
5.
Palma D, Bahig H, Hope A, Harrow S, Debenham B, Louie A, et al.
JAMA Oncol
. 2024 Mar;
10(5):575-582.
PMID: 38451491
Importance: Patients with interstitial lung disease (ILD) and early-stage non-small cell lung cancer (NSCLC) have been reported to be at high risk of toxic effects after stereotactic ablative radiotherapy (SABR),...
6.
Gulstene S, Lang P, Qu X, Laba J, Yaremko B, Rodrigues G, et al.
Radiother Oncol
. 2023 Nov;
190:109976.
PMID: 37918636
Purpose: Response EvaluationCriteriain Solid Tumors (RECIST) is commonly used to assess response to anti-cancer therapies. However, its application after lung stereotactic ablative radiotherapy (SABR) is complicated by radiation-induced lung changes....
7.
Kidane B, Gerard I, Spicer J, Kim J, Fiset P, Wawryko P, et al.
Cancer
. 2023 May;
129(18):2798-2807.
PMID: 37221679
Background: During coronavirus disease 2019 (COVID-19)-related operating room closures, some multidisciplinary thoracic oncology teams adopted a paradigm of stereotactic ablative radiotherapy (SABR) as a bridge to surgery, an approach called...
8.
Sartor O, Karrison T, Sandler H, Gomella L, Amin M, Purdy J, et al.
Eur Urol
. 2023 May;
84(2):156-163.
PMID: 37179241
Background: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. Objective: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of...
9.
Arifin A, Young S, Bauman G, Fakir H, Ahmad B, Laba J, et al.
Adv Radiat Oncol
. 2023 May;
8(5):101220.
PMID: 37124027
Purpose: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the...
10.
Arifin A, Tan V, Yan M, Warner A, Boldt R, Chen H, et al.
Adv Radiat Oncol
. 2023 Feb;
8(3):101178.
PMID: 36852015
Purpose: Although the frequency of noninferiority trials is increasing, the consistency of the reporting of these trials can vary. The aim of this systematic review was to assess the reporting...